Bestia Formulations Private Limited
About Bestia Formulations Private Limited
Data last updated:
Bestia Formulations Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2018PTC074271. Its GSTIN is 06AAHCB8490P1ZX (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Budh Singh and Kamal Kant.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #63 – 64 Mangla Colony Sonda Road, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.13 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹29,027 (net margin 0.8%) and EBITDA of ₹56,667 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 10% over five years.
Company details
Contact details
Bestia Formulations Private Limited's registered office is in Ambala, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address#63 – 64 Mangla Colony Sonda Road, Ambala, Haryana, India – 134003
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Bestia Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bestia Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bestia Formulations Private Limited, buy the company report.
Financials of Bestia Formulations Private Limited
FY 2025 filings availableBestia Formulations Private Limited reported revenue of ₹37.13 Lakh (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 39% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56,667 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29,027 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bestia Formulations Private Limited, buy the company report.
Board of directors of Bestia Formulations Private Limited
Bestia Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Budh Singh | Director | 20 Mar 2021 | 5 Years 7 Months | Current |
| Kamal Kant | Director | 25 May 2018 | 8 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Bestia Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bestia Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bestia Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCB8490P1ZX | Haryana | Active | 21 Jun 2018 |
To see the full GST registrations and return filing status of Bestia Formulations Private Limited, buy the company report.
Recent activity
Bestia Formulations Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Anjali Bansal ceased to be Director on 30 Mar 2021.
Frequently asked questions
Bestia Formulations is an active private limited company based in Ambala, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 May 2018 (8+ years old) and is registered under CIN U24290HR2018PTC074271.
Bestia Formulations has 2 current directors:
- Budh Singh - Director
- Kamal Kant - Director
The latest financial statements of Bestia Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Bestia Formulations is 06AAHCB8490P1ZX, registered in Haryana.
The CIN (Corporate Identification Number) of Bestia Formulations is U24290HR2018PTC074271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bestia Formulations was incorporated on 25 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.
Anjali Bansal ceased to be Director on 30 Mar 2021. Budh Singh was appointed as Director on 20 Mar 2021. Kamal Kant was appointed as Director on 25 May 2018.
The registered office of Bestia Formulations is at #63 – 64 Mangla Colony Sonda Road, Ambala, Haryana, India – 134003.
Bestia Formulations operates in the chemicals industry, in the manufacturing segment.
Bestia Formulations can be reached at its registered office: #63 – 64 Mangla Colony Sonda Road, Ambala, Haryana, India – 134003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
